Key terms
About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EW news
Yesterday 9:53am ET Micron upgraded, Foot Locker downgraded: Wall Street’s top analyst calls by TipRanks Yesterday 9:07am ET Edwards Lifesciences upgraded to Buy at BofA after ‘bullish’ management meetings by TipRanks Yesterday 6:03am ET Edwards Lifesciences upgraded to Buy from Neutral at BofA by TipRanks Feb 26 6:32am ET Edwards Lifesciences (EW) Gets a Buy from Wells Fargo by TipRanks Feb 12 5:47am ET Wells Fargo Reaffirms Their Buy Rating on Edwards Lifesciences (EW) by TipRanks Feb 08 6:57am ET Edwards Lifesciences price target raised to $100 from $90 at Barclays by TipRanks Feb 08 6:27am ET Barclays Remains a Buy on Edwards Lifesciences (EW) by TipRanks Feb 07 1:15pm ET Buy Rating Affirmed for Edwards Lifesciences on Evoque TTVR System’s FDA Approval and Promising Trial Results by TipRanks Feb 07 9:03am ET Edwards Lifesciences price target raised to $86 from $64 at Deutsche Bank by TipRanks Feb 07 9:01am ET Edwards Lifesciences price target raised to $95 from $82 at RBC Capital by TipRanks Feb 07 8:41am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP) by TipRanks Feb 07 8:38am ET Edwards Lifesciences price target raised to $86 from $81 at Canaccord by TipRanks Feb 07 8:28am ET Maintaining Hold on Edwards Lifesciences Amid Balanced Growth and Adequate Valuation by TipRanks Feb 07 8:12am ET Edwards Lifesciences price target raised to $97 from $84 at Truist by TipRanks Feb 07 7:56am ET Edwards Lifesciences (EW) Receives a Buy from Oppenheimer by TipRanks Feb 07 7:31am ET Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Edwards Lifesciences (EW) and Omnicell (OMCL) by TipRanks Feb 07 7:25am ET Edwards Lifesciences price target raised to $100 from $90 at TD Cowen by TipRanks Feb 07 7:01am ET Edwards Lifesciences price target raised to $92 from $84 at UBS by TipRanks Feb 07 6:53am ET Edwards Lifesciences price target raised to $100 from $85 at Baird by TipRanks Feb 07 6:49am ET Edwards Lifesciences price target raised to $95 from $85 at Mizuho by TipRanks Feb 07 6:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Edwards Lifesciences (EW) and Doximity (DOCS) by TipRanks Feb 06 4:29pm ET Edwards Lifesciences sees Q1 adjusted EPS 62c-66c, consensus 66c by TipRanks Feb 06 4:23pm ET Edwards Lifesciences sees Q1 adjusted EPS 62c-66c, consensus by TipRanks Feb 06 4:23pm ET Edwards Lifesciences backs FY24 adjusted EPS $2.70-$2.80, consensus $2.76 by TipRanks Feb 06 4:20pm ET Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 64c by TipRanks Feb 06 3:25pm ET Edwards Lifesciences options imply 5.5% move in share price post-earnings by TipRanks Feb 06 1:53pm ET Notable companies reporting after market close by TipRanks Feb 06 8:10am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Astria Therapeutics (ATXS) and Inspire Medical Systems (INSP) by TipRanks Feb 05 10:07am ET Balancing Positives and Uncertainties: Hold Rating on Edwards Lifesciences by TipRanks Feb 05 4:50am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW) by TipRanks Feb 03 1:06pm ET Maintaining Hold on Edwards Lifesciences Amidst EVOQUE Approval and Emerging Competition by TipRanks
No recent news articles are available for EW
No recent press releases are available for EW
EW Financials
1-year income & revenue
Key terms
Ad Feedback
EW Forecasts
analyst rating
- buy
- hold
- sell
We're sorry, but this
information is
temporarily unavailable.
1-year stock price forecast
EW Competitors
$ Market cap P/E ratio $ Price 1d change 52-week range
